Furthermore, by blocking the advantageous antitumor immunity, a subpopulation of suppressive T cells called CD4+CD25+ regulatory T cells (Tregs) add to the immune suppression seen in hepatocellular carcinomas (HCCs) patients (39–41). This evidence concerns the gene CD4 and hepatocellular carcinoma.